未登录

A

Andrew M. Strassman

Harvard University

H指数:45

被引数:8,173

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mapping Dural and Periosteal SV2C, a Botulinum Toxin A Receptor, in the Mouse

绘制小鼠硬脑膜和骨膜SV2C（肉毒杆菌毒素A受体）的分布图谱

Toxins 2025, Vol. 17, Page 509

IF0

2025-10-170

OAAI

OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to CSD in female mice

奥纳肉毒杆菌毒素A改变了雌性小鼠中硬脑膜巨噬细胞对CSD的促炎和抗炎反应。

IF4.6

2025-09-260

OA

Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache

ATP敏感性钾通道的开放激活了硬脑膜痛觉感受器：对偏头痛头痛起源的启示

IF4.6

2025-08-110

OA

Activation and sensitization of meningeal nociceptors by PACAP-38: implications for migraine headache

PACAP-38对硬脑膜伤害性感受器的激活和敏化：对偏头痛的启示

IF11.7

2025-08-060

OAAI

Exploring the effects of extracranial injections of botulinum toxin type A on activation and sensitization of central trigeminovascular neurons by cortical spreading depression in male and female rats

IF4.6

2024-09-090

PRE

Novel insight into atogepant mechanisms of action in migraine prevention

IF11.7

2024-02-274

OAAI

Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD

IF4.6

2022-03-2517

OA

OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood-brain barrier

IF5.5

2021-03-164

OA

Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons

IF4.6

2020-11-1727

OAAI

Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood-brain barrier

Fremanezumab及其同种型减慢了血脑屏障受损大鼠的传播速度并缩短了皮质恢复期，但不能阻止皮质扩散抑制的发生

IF5.5

2019-12-2423

OAAI

Celecoxib reduces cortical spreading depression-induced macrophage activation and dilatation of dural but not pial arteries in rodents: implications for mechanism of action in terminating migraine attacks

IF5.5

2019-12-2411

OAAI

Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier

IF4.6

2019-12-1963

OAAI

Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats

IF4.6

2019-08-3131

OAAI

Activation of pial and dural macrophages and dendritic cells by cortical spreading depression

ANNALS OF NEUROLOGY

IF7.7

2018-03-1372

OAAI

Reward deficiency and anti-reward in pain chronification

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2016-09-01156

OAAI

Cranial dural permeability of inflammatory nociceptive mediators: Potential implications for animal models of migraine

IF4.6

2016-08-1913

OAAI

Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?

IF4.6

2016-07-11102

OAAI

Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors

ANNALS OF NEUROLOGY

IF7.7

2013-06-1753

OAAI

A new animal model of headache: Ongoing pain vs stimulus-evoked hypersensitivity

IF4.6

2013-06-136

OAAI

Can cortical spreading depression activate central trigeminovascular neurons without peripheral input? Pitfalls of a new concept

IF4.6

2012-02-1612

OAAI